Dec. 12, 2025 — Aurora Cannabis Inc. stock (NASDAQ: ACB; TSX: ACB) is in focus Friday as cannabis equities broadly rally on fresh reporting that President Donald Trump is considering steps to loosen federal marijuana restrictions, including directing agencies toward reclassifying marijuana as a Schedule III drug . ^[1]

In pre-market trading, Aurora Cannabis (ACB) rose about 15% alongside other cannabis names, reflecting how quickly US federal policy headlines can re-rate sentiment across the sector—even for Canada-based operators with international medical exposure. ^[2]

What’s driving Aurora Cannabis stock today

1) Cannabis stocks surge after Schedule III reporting

The day’s main catalyst is reporting that Trump is expected to push a…